Login

Blood protein test may predict traumatic brain injuries in under 15 minutes, says new research

For some test subjects, CT scan results were negative but MRI showed intracranial abnormalities

Blood protein test may predict traumatic brain injuries in under 15 minutes, says new research

A new study has found that conducting a certain type of blood protein test in less than 15 minutes to predict intracranial abnormalities may affect clinical practice worldwide.

The study, which was published in the Journal of Neurotrauma, contemplates the use of a handheld, point-of-care device that measures glial fibrillary acidic protein. The researchers found this blood protein to be a promising diagnostic biomarker for predicting intracranial injuries among patients with traumatic brain injuries. The researchers conducted the study using a prototype device manufactured by Abbott Laboratories.

The study noted that, for more than 25 per cent of the test subjects, their CT scan results returned negative, but their MRI results showed intracranial abnormalities consistent with traumatic brain injuries. These patients had an elevated level of GFAP, the study found.

The new test, if approved, may lead to an accurate determination of the injury’s severity, faster diagnoses and earlier treatment for patients with traumatic brain injuries, the study suggests.

Dr. David Okonkwo, director of the Neurotrauma Clinical Trials Center led the study, which was called Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.

A blog post written on behalf of Cuming & Gillespie explored the implications of this new research for the approximately 1.5 million individuals in Canada who are affected by acquired brain injuries. In the country, the most common causes of traumatic brain injuries are falls and motor vehicle accidents, stated the blog post.

Traumatic brain injuries vary in severity, in the immediacy of their effects and in their impact on the victim’s life, which may even be permanent, said the blog post. Victims also experience different combinations of symptoms, such as fatigue, slurred speech, altered vision, sleep troubles, dizziness, headaches, chronic pain and difficulties in writing, making conversation, comprehending information, making plans or starting tasks.

Related stories

Free newsletter

The Canadian Legal Newswire is a FREE newsletter that keeps you up to date on news and analysis about the Canadian legal scene. A separate InHouse Edition is delivered on a regular basis, providing targeted news and information of interest to in-house counsel.

Please enter your email address below to subscribe.

Recent articles & video

Appellant’s conduct signalled agreement to pre-incorporation contract, SCC finds

Former lawyers file complaint with Manitoba Human Right Commission over courthouse accessibility

N.B. law society urged to require members, articling students to take domestic violence course

Solving the ‘problem-solution’ problem for patent applicants: Choueifaty decision

Businesses may obtain cyber certification via CyberSecure Canada’s web portal

COVID-19 and the courts: Oct. 26 update

Most Read Articles

Cybersecurity due diligence becomes focus in M&A transactions

New Brunswick case a reminder careful wording is needed in termination letters, employment contracts

What corporate lawyers really do: Konata Lake on why he loves what he does at Torys

Disciplining a nurse who criticized long-term care via social media infringes free speech: case